GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Myriad Genetics Inc (LTS:0K3W) » Definitions » Other Gross PPE

Myriad Genetics (LTS:0K3W) Other Gross PPE : $282.0 Mil (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Myriad Genetics Other Gross PPE?

Myriad Genetics's Other Gross PPE for the quarter that ended in Dec. 2024 was $282.0 Mil.

Myriad Genetics's quarterly Other Gross PPE increased from Jun. 2024 ($287.1 Mil) to Sep. 2024 ($290.1 Mil) but then declined from Sep. 2024 ($290.1 Mil) to Dec. 2024 ($282.0 Mil).

Myriad Genetics's annual Other Gross PPE increased from Dec. 2022 ($296.5 Mil) to Dec. 2023 ($300.5 Mil) but then declined from Dec. 2023 ($300.5 Mil) to Dec. 2024 ($282.0 Mil).

Myriad Genetics Other Gross PPE Historical Data

The historical data trend for Myriad Genetics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myriad Genetics Other Gross PPE Chart

Myriad Genetics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 209.90 232.20 296.50 300.50 282.00

Myriad Genetics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 300.50 288.20 287.10 290.10 282.00

Myriad Genetics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Myriad Genetics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Myriad Genetics Inc (LTS:0K3W) » Definitions » Other Gross PPE
Comparable Companies
CSTL FLGT CDNA PSNL STIM ATLN OPK NEOG LDDD ACRS TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT
Traded in Other Exchanges
MYGN:USA MYD:Germany
Address
322 North 2200 West, Salt Lake City, UT, USA, 84116
Website
https://www.myriad.com
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

Myriad Genetics Headlines

No Headlines